Skip to main content
. 2012 Feb 8;83(1):80–86. doi: 10.3109/17453674.2011.590761

Table 1.

Clinical characteristics of 54 patients with prostate cancer who were operated for metastatic spinal cord compression (SCC)a

Hormone status
Hormone-naïve b Hormone-refractory c
Clinical characteristics (n = 13) (n = 41)
Age at diagnosis of primary tumor 77 (60–85) 69 (51–86)
Age at surgery for SCC 77 (60–85) 72 (54–88)
PSA at diagnosis of primary tumor (ng/mL) 140 (21–4,000) 82 (2–7,300)
PSA at surgery for SCC (ng/mL) 140 (21–3,704) 190 (0.5–5,139) d
Interval between primary tumor diagnosis and surgery for SCC (months) 0 34 (3.5–216)
Gleason score of primary tumor: 6 0 2
7 1 14
8 1 6
9 1 6
10 0 3
Not available 10 10
Other sites of metastasis at the time of surgery for SCC e
 Abdominal organs 0 3
 Pelvic organs 0 3
 Lymph nodes 0 9
 Lung 0 3
 Other bones 11 41
Preoperative Frankel grade: f A 0 0
B 0 3
C 12 33
D 1 5
E 0 0

a Values are given as median (min–max) or absolute numbers (number of patients).

b Diagnosed with prostate cancer as a result of pain or neurological symptoms from spinal metastasis.

c Patients with disease progression after long-term androgen deprivation therapy.

d PSA values were not available for 3 patients.

eVisceral metastases were registered in 12 patients in the hormone-refractory group.

Patients may have more than one metastasis.

fGrade A: complete lesion (paraplegia); grade B: only sensory function; grade C: motor function present but not of practical use (non-ambulatory); grade D: motor function present, sufficient to allow walking (ambulatory); grade E: no neurological symptoms.